Related Experiment Video
Updated: May 30, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Role of Apoptotic Proteins in REC-2006 Mediated Radiation Protection in Hepatoma Cell Lines
Pankaj Kumar Singh1, Raj Kumar, Ashok Sharma
1Institute of Nuclear Medicine and Allied Sciences, Delhi, India.
Abstract:
The present study was carried out to evaluate the role of apoptotic proteins in REC-2006-mediated radiation protection in hepatoma cell lines. REC-2006 treatment 2 h before irradiation strongly inhibited the cleavage of ATM and PARP-1 in HepG2 cells. The expression of nuclear apoptosis inducing factor (AIF) was found to be more inhibited (~17%) in HepG2 cells in REC-2006 + radiation-treated group. More inhibition (~33%) of cytochrome c was observed in HepG2 cells upon REC-2006 treatment 2 h prior irradiation. Similarly, significantly more (P<.05) inhibition of Apaf-1, caspase-9 and caspase-3 was observed in REC-2006 + radition-treated group in HepG2 cells. REC-2006 treatment restored the expression of ICAD in HepG2 cells; however, no restoration was observed in Hep3B cells. Lower nuclear to cytoplasmic CAD ratio was observed in HepG2 cells (~0.6) as compared with Hep3B cells (~1.2) in REC-2006 + radiation-treated group. In conclusion, REC-2006 rendered higher protection in HepG2 cells by inhibiting the expression and translocation of AIF, inhibiting the cleavage of ATM and PARP-1, restoring the expression of ICAD, inhibiting the release of cytochrome c and thus modulating the expression of Apaf-1 caspase-9 and activity of caspase-3.
Insights
REC-2006 enhances radiation protection in hepatoma cells by modulating apoptotic protein pathways. It inhibits key protein cleavage and cytochrome c release, offering greater protection in HepG2 cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Radiation Oncology
Background:
- Hepatoma cell lines are susceptible to radiation-induced apoptosis.
- Understanding the role of apoptotic proteins is crucial for developing radioprotective agents.
Purpose of the Study:
- To evaluate the radioprotective role of REC-2006 in hepatoma cells.
- To investigate the involvement of apoptotic proteins in REC-2006-mediated protection.
Main Methods:
- Hepatoma cell lines (HepG2 and Hep3B) were treated with REC-2006 prior to irradiation.
- Expression and cleavage of apoptotic proteins including ATM, PARP-1, AIF, cytochrome c, Apaf-1, caspase-9, caspase-3, ICAD, and CAD were analyzed.
Main Results:
- REC-2006 inhibited cleavage of ATM and PARP-1, and reduced expression/translocation of AIF and cytochrome c in HepG2 cells.
- REC-2006 significantly inhibited Apaf-1, caspase-9, and caspase-3 in HepG2 cells.
- REC-2006 restored ICAD expression and lowered the nuclear to cytoplasmic CAD ratio in HepG2 cells, but not in Hep3B cells.
Conclusions:
- REC-2006 provides significant radioprotection to HepG2 cells by modulating multiple apoptotic pathways.
- REC-2006's protective mechanism involves inhibiting AIF translocation, ATM/PARP-1 cleavage, cytochrome c release, and caspase activation.
- Differential effects of REC-2006 were observed between HepG2 and Hep3B cell lines, suggesting cell-specific responses.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
